Showing results (61-70 of 239) with videos related to
Sort By:
Pageof 24
Schweizerische Medizinische Wochenschrift|March 14, 1992
[Is it justifiable today to perform thrombolysis in only one fifth of the patients with myocardial infarct?]C Sarasin, M Pfisterer, P WeissJournal of Human Hypertension|February 18, 2006
Substantial intraindividual variability of BNP concentrations in patients with hypertensionD Conen, M Pfisterer, B MartinaScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1984
Antianginal drug effects on normal, ischemic and scar myocardial segments in manM Pfisterer, R Fridrich, F BurkartJournal of Medical Virology|May 22, 2001
Genetic relatedness of Cuban HAV wild-type isolatesB I Diaz, C A Sariol, A Normann, et al.The Journal of Infection|July 1, 1997
Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccineB Flehmig, H Staedele, C Xueref, et al.Schweizerische Medizinische Wochenschrift|April 17, 1976
[Therapy of supraventricular arrhythmias with a cardioselective beta-receptor blocker (tolamolol)]M Pfisterer, J Halter, F NagerTherapeutische Umschau. Revue Therapeutique|August 1, 1991
[Diagnostic procedures in patients with known coronary heart disease]S Osswald, M Pfisterer, F BurkartTherapeutische Umschau. Revue Therapeutique|March 13, 2002
[Which patients with acute coronary syndrome without ST segment elevation should be handled invasively/interventionally when?]C Kaiser, N Balmelli, M PfistererThe American Journal of Cardiology|April 3, 1990
Direct vascular and myocardial effects of nisoldipineW Kiowski, M Pfisterer, F BurkartJournal of Cardiovascular Pharmacology|August 1, 1988
Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramideM Pfisterer, A Munoz, F BurkartPageof 24